AI
KRTX

Atom Investors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Atom Investors’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-101,205
Closed -$1.65M – 335
2019
Q3 		$1.65M Sell
101,205
-34,402
-25% -$669K 0.11% 164
2019
Q2 		$2.71M Buy
+135,607
New +$2.71M 0.18% 158

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Atom Investors's KRTX Position: Q4 2019 in Review

Atom Investors sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q4 2019, closing a stake of 101,205 shares — an estimated $1.65M sold.

Atom Investors first reported a position in KRTX in Q2 2019 and held it in 2 quarters. The position peaked at $2.71M in Q2 2019. 85 funds tracked by Wall St. Rank hold KRTX as of Q4 2019.

  • Atom Investors reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Atom Investors sold 101,205 Karuna Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $1.65M.
  • Atom Investors first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
  • Atom Investors's Karuna Therapeutics, Inc. Common Stock position peaked at $2.71M in Q2 2019.
  • 85 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Atom Investors's 13F filing for Q4 2019, filed 13 Feb 2020.